for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-FDA Advised COVID-19 Vaccine Makers EUA Request Should Have At Least 2 Months Follow-up Data

Oct 6 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA STAFF SAYS OCT 22 PANEL MEETING TO DISCUSS STUDIES TO TEST SAFETY, EFFICACY OF COVID-19 VACCINE CANDIDATES: BRIEFING DOCUMENTS

* U.S. FDA SAYS ADVISED COVID-19 VACCINE MAKERS THAT EUA REQUEST SHOULD HAVE DATA THAT INCLUDES A FOLLOW-UP DURATION OF AT LEAST TWO MONTHS Source text: (bit.ly/3d5Seju)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up